How continuous bioprocessing is breaking the $50/g barrier

How continuous bioprocessing is breaking the $50/g barrier

Downstream processing accounts for up to 60% of mAb manufacturing costs, and conventional protein A batch approaches have hit their limit. This video explores how integrated continuous bioprocessing can drive costs below $50 per gram. Watch Jean-Marc Cappia’s presentation at BPI Europe as he shows how you can leverage advanced cost modeling to demonstrate what scalable, efficient, and sustainable mAb manufacturing looks like in practice.

 

Key takeaways:

  1. See why downstream processing is the primary barrier to bringing costs below $50 per gram.
  2. Discover how integrated continuous bioprocessing eliminates the inefficiencies of conventional batch manufacturing.
  3. Explore how you can use advanced automation and cost modeling to enable scalable, sustainable mAb production. 

icon-shopping-cart
Ready to Buy?